My Heart Life

There are 1.2 million Americans suffer from cancer each year. Most health insurance does not cover these “specified disease” or “dread disease”. The costs of cancer diagnosis, operation or disposal and treatment of cancer are overwhelming for the victims and their families. I should know, some of my family members died in the last 13 years from cancer. Newly diagnosed cancer patients insurance can help ease these financial burdens, and give peace to you and yourFamily.

What many people do not realize is very regular health insurance does not cover cancer treatment. Although some measures a few diagnostic tests for cancer, or minimal treatment, they are not the entire spectrum of cancer care. Some treatments are very expensive. Expenses for travel expenses to the treatment of cancer facility not covered by health insurance.

My friend the woman had cancer and I thank God that they have survived. During the treatment,They had to coordinate the transport of friends at a get her, her daily treatments. This caused a lot of stress on my friend. After this experience, 3 years ago I bought myself a cancer insurance that covers my family. I pay about $ 88 U.S. dollars a month. It would have been $ 47 cheaper, but I got a the kind that all of my premiums to me after 25 years, minus any money that has paid on debts. So, if I do not have a right, I get back all my awards. I am still amazed at howrobust is the plan. It has a driver $ 350 per pay them to pay me if each of us radiotherapy or chemotherapy must be undertaken. This would not be for me to work or to cover transportation costs or rent it to friends, I need help in any way. You should not rent to friends, but no friendship can deposit in the bank either. My plan is virtually free because it pays for my wife and I are on our annual cancer screening. It is worth the greater of $ 50 or actual costs. Even when I was a member of an HMOI am simply the itemized statement and send it along into the application form. Because it is the insurance is a complement I receive the payment, even though I did not pay for the screening tests.http://www.healthplan.pannipa.com/2009/10/reality-check-cancer-not-covered-by-most-health-insurance-plans-cancer-insurance-to-the-rescue/

Cancer insurance is a supplement to health insurance to assure that the treatment and associated costs are covered, should emerge from this disease. The cover for this type of insurance may include:

• Applications will be during a stationary as well as outpatient treatment. These include radiation,Chemotherapy, drugs, etc.
• transportation and living expenses if the cancer treatment made out of the city. The payment of travel expenses for specialists may also be part of reporting.
• ambulance or air ambulance service, if required by the victim.
• Full-time care and facilities, if the treatment made from the residence of the victim.
• reconstruction and prosthesis can be part of the insurance.
• Specific diagnostic tests to determine necessary toType of cancer can be covered by the plan.http://www.healthplan.pannipa.com/2009/10/reality-check-cancer-not-covered-by-most-health-insurance-plans-cancer-insurance-to-the-rescue/

Article Source:http://www.articlesbase.com/health-articles/reality-check-cancer-not-covered-by-most-health-insurance-plans-cancer-insurance-to-the-rescue-1690070.html

My Heart Life Heart Health Fitness 13 Years, Cancer Care, Cancer Diagnosis, Cancer Insurance, Cancer Patients, Cancer Screening, Cancer Treatment, Cancer Treatments, Chemotherapy, Debts, Diagnostic Tests, Dread Disease, Family Members, Financial Burdens, Health Insurance, Premiums, Reality Check, Transportation Costs, Travel Expenses, Treatment Of Cancer

Through continuous research it has been demonstrated that this vitamin is also used to decrease the ability of breast cells to divide, stops tumor cells from growing, prevents new blood vessels from growing into a tumor, and also kills tumor cells. On top of this, it has also been proved that this can be used successfully as a means of boosting your immune system.

It is due to factors such as the above that US scientists claim high doses of vitamin D can reduce the risk of developing some common cancers, including breast cancer, by as much as 50%. These are staggering results, ones that shouldn’t be ignored! These results basically backup various studies that have been conducted that demonstrate if a person has sufficient levels of vitamin D, they have a considerably lower risk of developing cancer when compared to people with lower levels of said vitamin.

During research that was carried out by Cancer Treatment Centers of America, it was discovered that in all cancer patients, vitamin D deficiency was present. However it is said that as little as fifteen minutes of sunlight a day is enough vitamin D to reduce your risk of cancer by as much as 40%. On top of this you also have the option of gaining this vitamin from sources that include salmon, sardines, shrimp, milk, cod, and eggs.

Although the research that surrounds the use of vitamin D in terms of reducing your chance of gaining breast cancer is still ongoing, you can clearly see from the above there is a substantial amount of information already available to you; there is already a substantial amount of results from research that demonstrates the difference that vitamin D can make to your life in regards to keeping breast cancer at bay.

As I mentioned earlier, with all of the aspects that are supposed to be good and bad for us where your breast health is concerned it is hard to distinguish facts from fiction, which is why it is important to focus on the evidence. There is clearly evidence that suggests breast cancer can be helped through the use of vitamin D. With this in mind, I highly recommend that you seek the advice of your doctor to decide how best to alter your diet etc. so the inclusion of vitamin D fits nicely into it; especially as it could be just the thing to keep you from risk.

In summary, U.S. scientists have actually found vitamin D can reduce certain cancers, like breast cancer, by up to 50%. However, don’t overdo it! Excess vitamin D can have toxic side effects. Only 15 minutes of direct sunlight provides all that’s needed.

John Russell of IH Distribution, LLC brings you health, anti-aging and skin care products from around the world. Find fabulous skin care tips and great articles on a wide range of topics for women at our Skin Care Blog and http://www.hormones-beauty-health.com. In addition to skin care, they are also a great source for As Seen On TV Products. Don’t forget to check out their newly re-launched newsletter – filled with information you won’t find anywhere else.

Article Source:http://www.articlesbase.com/health-articles/can-vitamin-d-support-breast-health-part-iii-of-iii-1653431.html

My Heart Life Heart Health Fitness Blood Vessels, Boosting Your Immune System, Breast Cancer, Breast Cells, Breast Health, Cancer Patients, Cancer Treatment Centers, Cancer Treatment Centers Of America, Cancers, Continuous Research, Eggs, Fifteen Minutes, New Blood, Salmon, Sardines, Shrimp, Staggering Results, Sunlight, Tumor Cells, Vitamin D Deficiency

Terra med Alliance News: The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA’s Jonsson Comprehensive Cancer Center found.

Terra med Alliance News: The drug, when paired with a chemotherapy regimen, was even more effective in fighting ovarian cancer in cell lines in which signaling of the Src family kinases, associated with the deadly disease, is activated.

The study appears in the Nov. 10, 2009 edition of the British Medical Journal.

Ovarian cancer, which will strike 21,600 women this year and kill 15,500, causes more deaths than any other cancer of the female reproductive system. Few effective therapies for ovarian cancer exist, so it would be advantageous for patients if a new drug could be found that fights the cancer, said Gottfried Konecny, an assistant professor of hematology/oncology, a Jonsson Cancer Center researcher and first author of the study.

“I think Sprycel could be a potential additional drug for treating patients with Src dependent ovarian cancer,” Konecny said. “It is important to remember that this work is only on cancer cell lines, but it is significant enough that it should be used to justify clinical trials to confirm that women with this type of ovarian cancer could benefit.”

Recent gene expression studies have shown that about one-third of women have ovarian cancers with activated Src pathways, so the drug could potentially help 7,000 ovarian cancer patients every year.

In this study, the UCLA team tested the drug against 34 ovarian cancer cell lines and they conducted genetic analysis on all cell lines. Through these analyses, the researchers were able to identify genes that predict response to Sprycel. If the work is confirmed in human studies, it may be possible to test patients for Src activation and select those who would respond prior to treatment, personalizing their care.

“We were able to identify markers in the pre-clinical setting that would allow us to predict response to Sprycel,” Konecny said. “These may help us in future clinical trials in selecting patients for studies of the drug.”

Sprycel is what is known as a “dirty” kinase inhibitor, meaning it inhibits more than one pathway. Konecny said it also inhibits the focal adhesion kinase and ephrin receptor, also associated with ovarian cancer.

The next step, Konecny said, would be to test the drug on women with ovarian cancer in a clinical trial. The tissue of responders would then be analyzed to determine if the Src and other pathways were activated. If that is confirmed, it would further prove that Sprycel could be used to fight ovarian cancer. In studies, women would be screened before entering a trial and only those with Src dependent cancers could be enrolled to provide further evidence, Konecny said, much like the studies of the molecularly targeted breast cancer drug Herceptin enrolled only women who had HER-2 positive disease.

“Herceptin is different because we knew in advance that the only worked in women with HER-2 amplification,” he said. “In this case, we don’t clearly know that yet. The data reassure us that the drug works where the targets are over-expressed but we need more testing to confirm this.”

The tests combining the drug with chemotherapy are significant because chemotherapy currently is the first line treatment for ovarian cancer patients following surgery. Because Sprycel proved to have a synergistic effect when combined with chemotherapy — both made the other work better — it may be possible to add the targeted therapy as a first line treatment if its efficacy is confirmed in future studies, adding a new tool to an oncologist’s arsenal. Adapted from materials provided by University of California – Los Angeles, via EurekAlert!, a service of AAAS.

Terra med Alliance is a non-profit organization in the battle against leukemia  helps  children living with cancer and their families. Our goal is to make sure children battling cancer know they are not alone. For more information please visit www.terramedalliance.org.  Email at contact@terramedalliance.org

Terra med Alliance is a non-profit organization in the battle against leukemia helps children living with cancer and their families. Our goal is to make sure children battling cancer know they are not alone. For more information please visit www.terramedalliance.org. Email at contact@terramedalliance.org

Article Source:http://www.articlesbase.com/health-articles/health-terra-med-alliance-news-fda-approved-leukemia-drugs-shows-promise-in-ovarian-cancer-cells-1476314.html

My Heart Life Heart Health Fitness Alliance News, British Medical Journal, Cancer Cell, Cancer Patients, Center Researcher, Chemotherapy Regimen, Chronic Myeloid Leukemia, Comprehensive Cancer Center, Female Reproductive System, Food And Drug Administration, Gene Expression Studies, Hematology Oncology, Invasiveness, Jonsson Cancer Center, Jonsson Comprehensive Cancer Center, Ovarian Cancer, Ovarian Cancer Cells, Ovarian Cancers, Src Family, Ucla Team